Skip to content
MS
Sign in
Single-pathway Pathway metabolite unreviewed

Nascent VLDL

0
Pathways
0
Categories
0
As substrate
0
As product
What can this become? Show on map

Reactions involving Nascent VLDL

Every recorded step where this molecule takes part

All 2 Consumed 1 Produced 1

Showing all 2 reactions.

Recent literature

Refresh

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Hepatic Lipoprotein Production, Cardiometabolic Phenotypes, and Subtypes of Steatotic Liver Disease.

    Davidson NO. · 2026-06-04

    cited 1× unreviewed
  2. 2
    Exogenous Ganglioside GM3 Attenuates Atherosclerosis via Multi-Organ Modulation of Lipid Metabolism.

    Zhou J, Zhuang H, Sheng Q, Qiu Z, Chen Y. · 2026-04-29

    open access unreviewed
  3. 3
    VLDLR: A Multifunctional receptor in diverse pathophysiological processes.

    Wang X, Chen Y, Wei J, Li Y, Xu J, Dai T, Tang N, Han C, Zhou Y. · 2026-03-26

    open access unreviewed
  4. 4
    Seipin expression in hepatocytes impairs the assembly of VLDLs and exacerbates steatohepatitis.

    Dong Q, Ma Y, Chen X, Wang X, Liu Z, Liang C, Qiu L, Tang J, Wu J, Liu Y, Wu X, Zhou Y, Gao M, Yang H. · 2026-01-29

    cited 1× open access unreviewed
  5. 5
    A narrative review of impacts of apolipoproteins on atherosclerotic coronary plaques.

    Fukase T, Dohi T. · 2026-02-02

    open access unreviewed
  6. 6
    Mechanisms of scramblases in regulating hepatic lipoprotein secretion and autophagy.

    Chen A, Zhang C, Ding WX, Ni HM. · 2026-01-13

    cited 1× open access unreviewed
  7. 7
    Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives.

    Tamehri Zadeh SS, Toth PP, Banach M. · 2026-05-12

    open access unreviewed
  8. 8
    Ectopic FGFR1 Increases Intracellular Pool of Cholesterol in Prostate Cancer Cells.

    Liu Z, Ke Y, Hong T, Smith K, Davies P, Huang Y, Zhang D, Chakraborty S, Zhou Y, Wang F. · 2026-01-24

    open access unreviewed
  9. 9
    Hepatic targeting in ASCVD: integrating lipid lowering and inflammation modulation from statins to gene editing.

    Xiao Q, Wang M, Wang S, Wang L, Ding H. · 2026-01-29

    open access unreviewed
  10. 10
    Non-remnant triglyceride-rich lipoproteins due to lipoprotein lipase deficiency increase atherosclerosis in mice.

    Cabodevilla AG, Izquierdo MC, Basu D, Younis W, Tirumalasetty MB, Miao QR, Nasias D, Kanter JE, Ho TWW, Gjini… · 2026-01-03

    cited 3× open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.